Stout advised on the sale of United Plastics Group Inc. (UPG), a subsidiary of MedPlast, to an affiliate of Turnspire Capital Partners LLC. In connection with the transaction, Stout served as the exclusive financial advisor to both MedPlast and Baird Capital, of which MedPlast is a portfolio company. Founded in 1954, UPG is a manufacturer of precision injection-molded plastic and assembled components for its customers in the data-center, automotive, energy, and industrial markets. UPG operates three world-class manufacturing facilities - in Houston; Cardiff, Wales; and Suzhou, China - that offer a complete range of capabilities, including product design, engineering, rapid prototyping, and plastic injection molding. The company also provides a suite of other technology platforms, value-added assembly, and global supply chain management services. The UPG divestiture allowed MedPlast to continue focusing on its core medical business while affording UPG the opportunity to flourish under new ownership.